Biblio
Found 32 results
Author [ Title
] Type Year Filters: Author is Kerkvliet, Nancy I [Clear All Filters]
, “2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis Factor-$\alpha$ and Anti-CD40–Induced Activation of NF-$ąppa$B/Rel in dendritic cells: p50 Homodimer Activation is not affected”, Molecular pharmacology, vol. 62, pp. 722–728, 2002.
, “2,3,7,8-Tetrachlorodibenzo-p-dioxin Affects the Number and Function of Murine Splenic Dendritic Cells and Their Expression of Accessory Molecules”, Toxicology and Applied Pharmacology, vol. 171, no. 2, pp. 117 - 125, 2001.
, “Activation of the Aryl Hydrocarbon Receptor by 10-Cl-BBQ Prevents Insulitis and Effector T Cell Development Independently of Foxp3+ Regulatory T Cells in Nonobese Diabetic Mice.”, J Immunol, vol. 196, no. 1, pp. 264-73, 2016.
, “ Advertisement In utero Exposure of Mice to Dibenzo[a,l]Pyrene Produces Lymphoma in the Offspring: Role of the Aryl Hydrocarbon Receptor ”, Journal of Immunotoxicology, vol. 5, no. 1, pp. 81 - 91, 2008.
, “AhR activation increases IL-2 production by alloreactive CD4 T cells initiating the differentiation of mucosal-homing Tim3 Lag3 Tr1 cells.”, Eur J Immunol, vol. 47, no. 11, pp. 1989-2001, 2017.
, “Anti-androgen flutamide suppresses hepatocellular carcinoma cell proliferation via the aryl hydrocarbon receptor mediated induction of transforming growth factor-β1.”, Oncogene, 2015.
, “Anti-CD40 Treatment of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-Exposed C57Bl/6 Mice Induces Activation of Antigen Presenting Cells Yet Fails to Overcome TCDD-Induced Suppression of Allograft Immunity”, Toxicology and Applied Pharmacology, vol. 170, no. 1, pp. 10 - 22, 2001.
“The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor”, PLoS One, vol. 5, p. e13128, 2010.
, “The anti-inflammatory drug leflunomide is an agonist of the aryl hydrocarbon receptor.”, PLoS One, vol. 5, no. 10, 2010.
, “The aryl hydrocarbon receptor is required for induction of p21cip1/waf1 expression and growth inhibition by SU5416 in hepatoma cells.”, Oncotarget, vol. 8, no. 15, pp. 25211-25225, 2017.
, “The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.”, PLoS One, vol. 7, no. 7, p. e40926, 2012.
, “Aryl Hydrocarbon Receptor-Deficient Mice Generate Normal Immune Responses to Model Antigens and Are Resistant to TCDD-Induced Immune Suppression”, Toxicology and Applied Pharmacology, vol. 171, no. 3, pp. 157 - 164, 2001.
, “Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease.”, PLoS One, vol. 9, no. 2, p. e88726, 2014.
, “Contrasting the roles of costimulation and the natural adjuvant lipopolysaccharide during the induction of T cell immunity”, The Journal of Immunology, vol. 168, pp. 4372–4381, 2002.
, “CTL Hyporesponsiveness Induced by 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Role of Cytokines and Apoptosis”, Toxicology and Applied Pharmacology, vol. 166, no. 3, pp. 214 - 221, 2000.
, “Cutting edge: activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin generates a population of CD4+ CD25+ cells with characteristics of regulatory T cells.”, J Immunol, vol. 175, no. 7, pp. 4184-8, 2005.
, “Dibenzo[a,l]pyrene induced DNA adduct formation in lung tissue in vivo”, Cancer Letters, vol. 227, no. 1, pp. 25 - 32, 2005.
, “Dibenzo[a,l]pyrene induced DNA adduct formation in lung tissue in vivo.”, Cancer Lett, vol. 227, no. 1, pp. 25-32, 2005.
, “Early Consequences of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure on the Activation and Survival of Antigen-Specific T Cells”, Toxicological Sciences, vol. 82, no. 1, pp. 129 - 142, 2004.
, “Functional alterations in CD11b(+)Gr-1(+) cells in mice injected with allogeneic tumor cells and treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.”, Int Immunopharmacol, vol. 3, no. 4, pp. 553-70, 2003.
, “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells”, Biology (Basel), vol. 6, no. 4, 2017.
, “Identification of a Raloxifene Analog That Promotes AhR-Mediated Apoptosis in Cancer Cells.”, Biology (Basel), vol. 6, no. 4, 2017.
, “Influence of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on the Antigen-Presenting Activity of Dendritic Cells”, Toxicological Sciences, vol. 72, no. 1, pp. 103 - 112, 2003.
, “Mechanism of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4+ T cells: the roles of apoptosis, Fas, and TNF”, Toxicology, vol. 170, pp. 139–151, 2002.
, “Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands”, Journal of Medicinal Chemistry, vol. 52, no. 18, pp. 5635 - 5641, 2009.